Intersect ENT, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2021. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-06-03: Reporting owner Mead Dana G Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-03: Reporting owner Lucchese Cynthia L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-03: Reporting owner Kline Teresa L.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-06-03: Reporting owner GALLAHUE KIERAN; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-06-03 | Mead Dana G Jr. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,734 5,734 owned after | $16.50 exercise price | 2021-06-07 | |
| 2021-06-03 | Lucchese Cynthia L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,734 5,734 owned after | $16.50 exercise price | 2021-06-07 | |
| 2021-06-03 | Kline Teresa L. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,734 5,734 owned after | $16.50 exercise price | 2021-06-07 | |
| 2021-06-03 | GALLAHUE KIERAN Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,734 5,734 owned after | $16.50 exercise price | 2021-06-07 | |
| 2021-04-05 | Sandoval Elisabeth Director | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,896 15,896 owned after | $20.98 exercise price | 2021-04-07 | |
| 2021-03-16 | Kline Teresa L. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,390 3,390 owned after | $21.00 exercise price | 2021-03-18 | |
| 2021-03-16 | GALLAHUE KIERAN Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,390 3,390 owned after | $21.00 exercise price | 2021-03-18 | |
| 2021-03-16 | Lucchese Cynthia L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,390 3,390 owned after | $21.00 exercise price | 2021-03-18 | |
| 2021-03-10 | Hattangadi Neil A Director | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,993 13,993 owned after | $21.44 exercise price | 2021-03-29 | |
| 2021-02-01 | Kowalski Christine R Officer (EVP & Chief Operating Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,750 29,750 owned after | $23.07 exercise price | 2021-02-03 | |
| 2021-02-01 | MEIER RICHARD A Officer (EVP & Chief Financial Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,000 34,000 owned after | $23.07 exercise price | 2021-02-03 | |
| 2021-02-01 | West Thomas A. Director, Officer (President and CEO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +118,461 118,461 owned after | $23.07 exercise price | 2021-02-03 | |
| 2021-01-19 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 0 owned after | $0.72 exercise price | 2021-02-05 |